154 related articles for article (PubMed ID: 7790724)
1. A novel method to purify immunotoxins from free antibodies using modified recombinant toxins.
Dhanabal M; Fryxell DK; Ramakrishnan S
J Immunol Methods; 1995 Jun; 182(2):165-75. PubMed ID: 7790724
[TBL] [Abstract][Full Text] [Related]
2. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography.
Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ
J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hybrid toxin with dual enzymatic activities. Potential use in preparing highly effective immunotoxins.
Li BY; Ramakrishnan S
J Biol Chem; 1994 Jan; 269(4):2652-8. PubMed ID: 8300596
[TBL] [Abstract][Full Text] [Related]
4. Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B.
Knowles PP; Thorpe PE
Anal Biochem; 1987 Feb; 160(2):440-3. PubMed ID: 3495199
[TBL] [Abstract][Full Text] [Related]
5. A gelonin-containing immunotoxin directed against human breast carcinoma.
Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
[TBL] [Abstract][Full Text] [Related]
6. Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action.
Lidor YJ; O'Briant KC; Xu FJ; Hamilton TC; Ozols RF; Bast RC
J Clin Invest; 1993 Nov; 92(5):2440-7. PubMed ID: 8227359
[TBL] [Abstract][Full Text] [Related]
7. Immunoaffinity purification and quantification of antibody-toxin conjugates.
Wawrzynczak EJ; Cumber AJ
Methods Mol Biol; 1998; 80():145-53. PubMed ID: 9664371
[No Abstract] [Full Text] [Related]
8. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
Ramakrishnan S; Bjorn MJ; Houston LL
Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
[TBL] [Abstract][Full Text] [Related]
9. Preparation of cytotoxic antibody-toxin conjugates.
Cumber AJ; Wawrzynczak EJ
Methods Mol Biol; 1998; 80():135-44. PubMed ID: 9664370
[No Abstract] [Full Text] [Related]
10. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity.
Greenfield L; Johnson VG; Youle RJ
Science; 1987 Oct; 238(4826):536-9. PubMed ID: 3498987
[TBL] [Abstract][Full Text] [Related]
11. Purification and properties of immunotoxins containing one vs. two deglycosylated ricin A chains.
Ghetie V; Swindell E; Uhr JW; Vitetta ES
J Immunol Methods; 1993 Nov; 166(1):117-22. PubMed ID: 8228282
[TBL] [Abstract][Full Text] [Related]
12. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
13. Genetic construction of a phosphorylation site in ricin A chain: specific radiolabeling of recombinant proteins for localization and degradation studies.
Fryxell D; Li BY; Mohanraj D; Johnson B; Ramakrishnan S
Biochem Biophys Res Commun; 1995 May; 210(2):253-9. PubMed ID: 7755598
[TBL] [Abstract][Full Text] [Related]
14. Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies.
Vallera DA; Burns LJ; Frankel AE; Sicheneder AR; Gunther R; Gajl-Peczalska K; Pennell CA; Kersey JH
J Immunol Methods; 1996 Oct; 197(1-2):69-83. PubMed ID: 8890895
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
16. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
Pietersz GA; Kanellos J; McKenzie IF
Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
[TBL] [Abstract][Full Text] [Related]
17. Expression and secretion of a recombinant ricin immunotoxin from murine myeloma cells.
Krek CE; Ladino CA; Goldmacher VS; Blättler WA; Guild BC
Protein Eng; 1995 May; 8(5):481-9. PubMed ID: 8532670
[TBL] [Abstract][Full Text] [Related]
18. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
[TBL] [Abstract][Full Text] [Related]
19. Selective immunotoxins prepared with mutant diphtheria toxins coupled to monoclonal antibodies.
Colombatti M; Dell'Arciprete L; Rappuoli R; Tridente G
Methods Enzymol; 1989; 178():404-22. PubMed ID: 2513466
[No Abstract] [Full Text] [Related]
20. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
